Providing Today's Patients with Medicines of the Future
Simcere Project X, only for “daring explorers”!
On Jul. 16, 2024, Simcere Pharmaceutical (2096.HK) announced that the new drug application for Quviviq® (daridorexant hydrochloride tablets), ...
On June 25, 2024, Simcere Zaiming, an innovative oncology company and a subsidiary of Simcere Pharmaceutical Group (2096.HK), announced that Enlituo&a...
On June 2, 2024, Simcere Zaiming, a leading oncology company and subsidiary of Simcere Pharmaceutical Group Ltd., announced the presentation of the la...
Staff
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions